Amiodarone-induced thyrotoxicosis

被引：6
|
作者：
Schubert, Louis [1 ]
Bricaire, Leopoldine [1 ]
Groussin, Lionel [1 ,2 ,3 ]
机构：
[1] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France
[2] Univ Paris, F-75014 Paris, France
[3] Inst Cochin, Inserm Unite 1016, CNRS UMR 8104, F-75014 Paris, France
来源：
ANNALES D ENDOCRINOLOGIE | 2021年 / 82卷 / 3-4期
关键词：
Amiodarone; Thyrotoxicosis; Hyperthyroidism; ASSOCIATION; GUIDELINES; MANAGEMENT; TYPE-2; THYROIDECTOMY; CONTINUATION; THERAPY;
D O I：
10.1016/j.ando.2020.04.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：163 / 166
页数：4
相关论文
共 50 条
  • [31] Approach to the Patient with Amiodarone-Induced Thyrotoxicosis
    Bogazzi, Fausto
    Bartalena, Luigi
    Martino, Enio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06): : 2529 - 2535
  • [32] Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction
    Maqdasy, Salwan
    Batisse-Lignier, Marie
    Auclair, Candy
    Desbiez, Francoise
    Citron, Bernard
    Thieblot, Philippe
    Roche, Beatrice
    Lusson, Jean Rene
    Tauveron, Igor
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (07): : 1112 - 1116
  • [33] Successful treatment of amiodarone-induced thyrotoxicosis
    Osman, F
    Franklyn, JA
    Sheppard, MC
    Gammage, MD
    CIRCULATION, 2002, 105 (11) : 1275 - 1277
  • [34] Amiodarone/DiltiazemPersistent amiodarone-induced thyrotoxicosis and lack of efficacy
    Reactions Weekly, 2024, 1997 (1) : 21 - 21
  • [35] Amiodarone-Induced Thyrotoxicosis Late After Amiodarone Withdrawal
    Yagishita, Atsuhiko
    Hachiya, Hitoshi
    Kawabata, Mihoko
    Nakamura, Tomofumi
    Sugiyama, Koji
    Tanaka, Yasuaki
    Sasano, Tetsuo
    Isobe, Mitsuaki
    Hirao, Kenzo
    CIRCULATION JOURNAL, 2013, 77 (12) : 2898 - 2903
  • [36] Amiodarone/prednisoneLack of efficacy and amiodarone-induced thyrotoxicosis: case report
    Reactions Weekly, 2022, 1914 (1) : 37 - 37
  • [37] Amiodarone-induced thyrotoxicosis treated by thyroidectomy.
    LeCosquer, P
    GuerinRobardey, AM
    Ossart, M
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1996, 15 (07): : 1092 - 1094
  • [38] Amiodarone-induced thyrotoxicosis: A case for surgical management
    Franzese, CB
    Stack, BC
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2002, 23 (06) : 358 - 361
  • [39] EFFECTIVENESS OF DEXAMETHASONE IN THE TREATMENT OF AMIODARONE-INDUCED THYROTOXICOSIS
    SIMON, C
    SCHLIENGER, JL
    CHERFAN, J
    ROUL, G
    VIGNON, F
    CHABRIER, G
    IMLER, M
    PRESSE MEDICALE, 1984, 13 (45): : 2767 - 2767
  • [40] Anaesthesia for amiodarone-induced thyrotoxicosis: A case review
    Sutherland, J
    Robinson, B
    Delbridge, L
    ANAESTHESIA AND INTENSIVE CARE, 2001, 29 (01) : 24 - 29
12345